64 related articles for article (PubMed ID: 20571354)
21. Prospective assessment of XPD Lys751Gln and XRCC1 Arg399Gln single nucleotide polymorphisms in lung cancer.
Giachino DF; Ghio P; Regazzoni S; Mandrile G; Novello S; Selvaggi G; Gregori D; DeMarchi M; Scagliotti GV
Clin Cancer Res; 2007 May; 13(10):2876-81. PubMed ID: 17504986
[TBL] [Abstract][Full Text] [Related]
22. [Correlation of the sensitivity of NP chemotherapy in non-small lung cancer with DNA repair gene XRCC1 polymorphism].
Hong CY; Xu Q; Yue Z; Zhang Y; Yuan Y
Ai Zheng; 2009 Dec; 28(12):1291-7. PubMed ID: 19958624
[TBL] [Abstract][Full Text] [Related]
23. Survival rates and tolerability of platinum-based chemotherapy regimens for elderly patients with non-small-cell lung cancer (NSCLC).
Costa GJ; Fernandes AL; Pereira JR; Curtis JR; Santoro IL
Lung Cancer; 2006 Aug; 53(2):171-6. PubMed ID: 16757059
[TBL] [Abstract][Full Text] [Related]
24. Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.
Zhou W; Gurubhagavatula S; Liu G; Park S; Neuberg DS; Wain JC; Lynch TJ; Su L; Christiani DC
Clin Cancer Res; 2004 Aug; 10(15):4939-43. PubMed ID: 15297394
[TBL] [Abstract][Full Text] [Related]
25. Prediction of copper transport protein 1 (CTR1) genotype on severe cisplatin induced toxicity in non-small cell lung cancer (NSCLC) patients.
Xu X; Ren H; Zhou B; Zhao Y; Yuan R; Ma R; Zhou H; Liu Z
Lung Cancer; 2012 Aug; 77(2):438-42. PubMed ID: 22516052
[TBL] [Abstract][Full Text] [Related]
26. Genetic polymorphism and gene expression of microsomal epoxide hydrolase in non-small cell lung cancer.
Lin TS; Huang HH; Fan YH; Chiou SH; Chow KC
Oncol Rep; 2007 Mar; 17(3):565-72. PubMed ID: 17273734
[TBL] [Abstract][Full Text] [Related]
27. Randomized phase II trial comparing nitroglycerin plus vinorelbine and cisplatin with vinorelbine and cisplatin alone in previously untreated stage IIIB/IV non-small-cell lung cancer.
Yasuda H; Yamaya M; Nakayama K; Sasaki T; Ebihara S; Kanda A; Asada M; Inoue D; Suzuki T; Okazaki T; Takahashi H; Yoshida M; Kaneta T; Ishizawa K; Yamanda S; Tomita N; Yamasaki M; Kikuchi A; Kubo H; Sasaki H
J Clin Oncol; 2006 Feb; 24(4):688-94. PubMed ID: 16446342
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC).
Pereira JR; Martins SJ; Nikaedo SM; Ikari FK
BMC Cancer; 2004 Sep; 4():69. PubMed ID: 15456520
[TBL] [Abstract][Full Text] [Related]
29. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
[TBL] [Abstract][Full Text] [Related]
30. [Single nucleotide polymorphisms in XRCC1 and clinical response to platin-based chemotherapy in advanced non-small cell lung cancer].
Wang ZH; Miao XP; Tan W; Zhang XR; Xu BH; Lin DX
Ai Zheng; 2004 Aug; 23(8):865-8. PubMed ID: 15301704
[TBL] [Abstract][Full Text] [Related]
31. The relationship between polymorphisms of genes regulating DNA repair or cell division and the toxicity of platinum and vinorelbine chemotherapy in advanced NSCLC patients.
Powrózek T; Mlak R; Krawczyk P; Homa I; Ciesielka M; Kozioł P; Prendecka M; Milanowski J; Małecka-Massalska T
Clin Transl Oncol; 2016 Feb; 18(2):125-31. PubMed ID: 26193985
[TBL] [Abstract][Full Text] [Related]
32. Glutathione S-transferase P1 polymorphisms are associated with time to tumor progression in small cell lung cancer patients.
Saip R; Sen F; Vural B; Ugurel E; Demirkan A; Derin D; Eralp Y; Camlica H; Ustuner Z; Ozbek U
J BUON; 2011; 16(2):241-6. PubMed ID: 21766492
[TBL] [Abstract][Full Text] [Related]
33. Is class III beta-tubulin a true predictive marker of sensitivity to vinorelbine in non-small cell lung cancer? Chemosensitivity data evidence.
Hirai Y; Yoshimasu T; Oura S; Ota F; Naito K; Nishiguchi H; Hashimoto S; Okamura Y
Anticancer Res; 2011 Mar; 31(3):999-1005. PubMed ID: 21498728
[TBL] [Abstract][Full Text] [Related]
34. Prognostic significance of telomerase polymorphism in non-small cell lung cancer.
Catarino R; Araújo A; Coelho A; Gomes M; Nogueira A; Lopes C; Medeiros RM
Clin Cancer Res; 2010 Jul; 16(14):3706-12. PubMed ID: 20606038
[TBL] [Abstract][Full Text] [Related]
35. [Association between Ephb4 gene polymorphism and non-small cell lung cancer].
Shen LQ; Wang XC; Zhao J
Zhonghua Zhong Liu Za Zhi; 2009 Oct; 31(10):778-9. PubMed ID: 20021833
[No Abstract] [Full Text] [Related]
36. Identification of polymorphisms associated with hypertriglyceridemia and prolonged survival induced by bexarotene in treating non-small cell lung cancer.
Luo W; Schork NJ; Marschke KB; Ng SC; Hermann TW; Zhang J; Sanders JM; Tooker P; Malo N; Zapala MA; Dziewanowska ZE; Negro-Vilar A; Meglasson MD
Anticancer Res; 2011 Jun; 31(6):2303-11. PubMed ID: 21737656
[TBL] [Abstract][Full Text] [Related]
37. Gene expression and polymorphisms of DNA repair enzymes: cancer susceptibility and response to chemotherapy.
Camps C; Sirera R; Iranzo V; Tarón M; Rosell R
Clin Lung Cancer; 2007 May; 8(6):369-75. PubMed ID: 17562237
[TBL] [Abstract][Full Text] [Related]
38. The study of the relation of DNA repair pathway genes SNPs and the sensitivity to radiotherapy and chemotherapy of NSCLC.
Wang C; Nie H; Li Y; Liu G; Wang X; Xing S; Zhang L; Chen X; Chen Y; Li Y
Sci Rep; 2016 Jun; 6():26526. PubMed ID: 27246533
[TBL] [Abstract][Full Text] [Related]
39. Structural, functional analysis and association of MSH6 rs1800932, rs1042821 polymorphisms with clinical outcome in North Indian lung cancer patients treated with platinum-based doublet chemotherapy.
Singh S; Singh N; Baranwal M; Sharma S
Am J Med Sci; 2022 Dec; 364(6):735-745. PubMed ID: 35868444
[TBL] [Abstract][Full Text] [Related]
40. Regulatory single nucleotide polymorphisms at the beginning of intron 2 of the human KRAS gene.
Antontseva EV; Matveeva MY; Bondar NP; Kashina EV; Leberfarb EY; Bryzgalov LO; Gervas PA; Ponomareva AA; Cherdyntseva NV; Orlov YL; Merkulova TI
J Biosci; 2015 Dec; 40(5):873-83. PubMed ID: 26648033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
